MedPath

Advanced Radiological Image Analysis for Cancers

Phase 2
Conditions
Health Condition 1: null- Brain tumoursLung CancersHead and Neck cancersLymphomasHealth Condition 2: C329- Malignant neoplasm of larynx, unspecified
Registration Number
CTRI/2016/11/007484
Lead Sponsor
Tata Memorial Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. patients with head and neck squamous cell cancers, lymphomas, brain tumors and lung cancers

2. The diagnostic imaging data sets of patients of above mentioned tumour types should be available.

3. All available baseline CT (with and without - contrast), various MRI sequences and PET scan will be used for texture analysis

4. Patient should sign the informed consent form

Exclusion Criteria

Patients who are unable to sign the informed consent form.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.1 To asses heterogeneity exists in tumours of same species by image texture analysis. <br/ ><br>1.2 To quantify the heterogeneity by image texture analysis <br/ ><br>Timepoint: NI
Secondary Outcome Measures
NameTimeMethod
Event free survival (EFS)Timepoint: 2 YEARS;Local control ratesTimepoint: 2 years;Overall SurvivalTimepoint: 2 years;Progression free survival (PFS) <br/ ><br>Timepoint: 2 years;Response RateTimepoint: 2 months to 6 months
© Copyright 2025. All Rights Reserved by MedPath